Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Transdermal Skin Patches Market, and What Factors Will Drive It?
The market size of transdermal skin patches has seen consistent growth over the past few years. It is projected to rise from $7.46 billion in 2024 to $7.65 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 2.5%. The historical growth can be credited to the escalating occurrence of cardiovascular diseases, substantial economic growth in burgeoning markets, an upsurge in pharmaceutical research & development expenditure, and augmented healthcare spending.
Anticipated to experience consistent expansion in the coming years, the transdermal skin patches market is predicted to reach a valuation of $9.18 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 4.7%. The growth expected within the forecast period can be linked to factors such as the rise in smoking cessation, the fast-paced increase in older demographics, the climb in health-care spending, and a growing number of cardiovascular disease cases. Key trends projected to characterize the forecast period include technological improvements in transdermal skin patches, advancements in diabetes transdermal patches, vigorous research and development initiatives, product innovation, collaborations and partnerships, developments in wearable skin patches, strides in microneedle patches for vaccination, and the introduction of new iontophoresis patches.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp
What Are the Core Growth Drivers Propelling the Transdermal Skin Patches Market Forward?
The escalating cases of cardiovascular disease are anticipated to stimulate the transdermal skin patches market’s expansion. These are conditions that affect the heart and blood vessels and are typically associated with the formation of fatty sediment inside (atherosclerosis) arteries and an increased risk of blood clots. Transdermal skin patches are utilized to impede angina (chest pain) episodes in individuals diagnosed with coronary artery disease – a condition where blood vessels supplying blood to the heart become narrow. These patches are also applied to enhance bioavailability in heart failure treatment. For instance, a report by the American College of Cardiology, a US-based non-profit medical organization, stated in August 2022 that the four main cardiovascular risk factors in the US were expected to surge between 2025 and 2060. Diabetes is predicted to see the highest percentage increase, rising 39.3% to 55 million individuals, followed by dyslipidemia (growing 27.6% to 126 million), hypertension (rising by 25.1% to 162 million), and obesity (expanding by 18.3% to 126 million). The study also noted that stroke (33.8% to 15 million) and heart failure (33.4% to 13 million) were predicted to have the most noticeable increases in cardiovascular disease rates, followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Therefore, the rise in cardiovascular disease cases is fueling the expansion of the transdermal skin patches market.
What Segment Types Define the Transdermal Skin Patches Market Structure?
The transdermal skin patches market covered in this report is segmented –
1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications
Subsegments:
1) By Matrix: Drug-in-matrix Patches, Polymer Matrix Patches
2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer
3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug, Multi-layer Reservoir Patches
4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form, Transdermal Patches Utilizing Vaporization Technology
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2829&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Transdermal Skin Patches Market?
North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing theTransdermal Skin Patches Industry Evolution?
Companies that dominate the transdermal skin patches market are targeting their efforts on developing innovative goods and securing their approval to establish an edge over their competitors. These groundbreaking items are aimed at providing new or enhanced solutions, such as medications, medical equipment, or other commodities, to pre-existing challenges or necessities. A case in point is Noven Pharmaceuticals Inc., an American pharmaceutical firm, which in March 2022 announced that XELSTRY (dextroamphetamine) transdermal system had received the green light from the U.S. Food and Drug Administration (FDA), a federal agency of the U.S. This system represents the first and only approved amphetamine patch designed for ADHD (Attention-Deficit or Hyperactivity Disorder) treatment. XELSTRYM ought to be utilized two hours prior to when the effect is needed and should be removed after nine hours. The final dosage should be adjusted according to the clinical response and tolerability.
View the full report here:
https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report
What Is the Definition of the Transdermal Skin Patches Market?
Transdermal skin patches refer to a drug delivery technique where a pre-prescribed dose of medication is applied as an adhesive patch and absorbed via the skin into the bloodstream. They deliver a precise, pre-set dosage of medication that is absorbed into the bloodstream through the skin.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2829
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model